MYX 2.52% $4.26 mayne pharma group limited

Mayne Pharma sees strong sales growth in FY 2023, page-70

  1. 947 Posts.
    lightbulb Created with Sketch. 66
    There is actually 70 m savings in operating expenses , so Mayne is operating both Nexstellis and TXMD at profit for the first time , so they are correct 14 m +ve contribution and international segment always making profit , hopefully they add more dermatology products from similar companies to use the existing sales force . Smart idea
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.26
Change
-0.110(2.52%)
Mkt cap ! $362.4M
Open High Low Value Volume
$4.36 $4.36 $4.25 $253.7K 59.12K

Buyers (Bids)

No. Vol. Price($)
3 1090 $4.25
 

Sellers (Offers)

Price($) Vol. No.
$4.26 2303 4
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.